Legal experts suggest to cancel the reimbursement of low efficacy drugs and save social insurance expenses

Source: Global Network August 20, 2015 according to the European times on August 17, Ms Borden, a consultant of the leadership of CNAM, advocated a comprehensive reform of drug reimbursement rate She suggested eliminating the 15% reimbursement rate and setting up a unified reimbursement rate Ms Borden is the head of the working group on "health care product evaluation" According to French media, she mainly proposed to cancel the 15% reimbursement rate At present, France implements three reimbursement rates according to the level of SMR Reimbursement for high efficacy is 65%, reimbursement for general efficacy is 30%, and reimbursement for low efficacy is 15% The level of efficacy is assessed by the transparency Committee of the senior health administration (has) based on a number of factors, such as the severity of the disease, the pros and cons of public health, side effects, and the effectiveness of disease prevention or treatment "In principle, it's not ridiculous not to reimburse inefficient drugs any more, but we should be cautious," said Dr ubedel, chief financial officer of the mgfrance When social security institutions reduce the reimbursement rate of drugs, or simply do not reimburse, there will be a delay effect The prescribing doctor will point out to the patient another medicine that can be reimbursed, even if it is more expensive or has side effects " Ms Bordeaux has also studied other options, such as setting up a unified reimbursement rate (the rate is not yet determined) and setting up a "temporary exceptional reimbursement rate", which involves drugs with low efficacy but no alternative drugs In order to make up for the decrease in reimbursement rate, the expert also suggested that a reimbursement quota system should be established for non reimbursable drugs This can only involve some patients and will be strictly controlled The recommendations adopted will be submitted to the working group on 18 September, the report said These measures can mainly make the state curb the growth of the expenditure of social insurance institutions and achieve savings (Sarah)